KENYON LAWRENCE A
Insider CIK 1230484 · ARNI Chief Financial Officer · OTLK Chief Financial Officer, Director · ACEL President, CEO and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics, Inc. | P Buy deriv | 2026-08-14 | 2026-08-14 | 101,010 | — | $0 | 101,010 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-08-14 | 2026-08-14 | 101,010 | — | $0 | 106,956 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy deriv | 2026-08-14 | 2026-08-14 | 101,010 | — | — | 101,010 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-08-14 | 2026-08-14 | 101,010 | — | — | 106,956 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2026-07-21 | 2026-07-23 | 210,078 | — | $0 | 210,078 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2024-09-26 | 2024-09-30 | 5,000 | $5.69 | $28.5K | 5,946 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-03-20 | 2024-03-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2021-04-20 | 2021-04-20 | 10,000 | $1.83 | $18.3K | 18,926 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-01 | 2020-10-05 | 3,668,984 | — | $0 | 3,668,984 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 450,000 | — | $0 | 450,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-20 | 216,435 | — | $0 | 216,435 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | S Sale | 2019-09-18 | 2019-10-15 | 1,350 | $1.70 | $2.3K | 8,926 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | S Sale | 2019-09-18 | 2019-09-23 | 1,350 | $1.70 | $2.3K | 80,863 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-09-12 | 2019-09-13 | 450,000 | — | $0 | 450,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-02-19 | 2019-02-19 | 800,000 | — | $0 | 800,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2019-02-07 | 2019-02-08 | 25,000 | $0.90 | $22.5K | 82,213 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2018-09-18 | 2018-09-18 | 10,100 | $0.87 | $8.8K | 57,213 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-08-01 | 2018-08-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2017-12-22 | 2017-12-26 | 26,165 | $1.13 | $29.6K | 67,313 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2016-12-21 | 2016-12-22 | 50,000 | — | $0 | 93,478 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2014-02-24 | 2014-02-26 | 223,445 | — | $0 | 223,445 | SEC↗ |
| ACEL Tamir Biotechnology, Inc. | A Award deriv | 2012-07-23 | 2012-07-25 | 400,000 | — | $0 | 400,000 | SEC↗ |